View Author
scopus: 7006156103

Rutten, W.P.F.

(Wim Rutten)


lipid level study plasma estimate population heritability disease <0.001 plasma lipids individual signi hormone replacement therapy family cholesterol analysis variance lipoprotein cholesterol mutation therapy e ffects ratio genet heritabilitie apolipoprotein pedigree lipid levels slc 11a lipoprotein genotype model covariate trait table nature body mass index outcome apoe genotype blood lipid-lowering therapy result association ficant p-value signi ficant tc /hdl ratio factor center polymorphism diabetes heritability estimates variant protein netherland e ffect erasmu di fferences ficantly apolipoprotein e status fficient quartile value alcohol variation replacement hormone research center fferent /or transferrin saturation intracellular iron levels plasma lipid levels systolic blood pressure triglycerides fference apolipoprotein e polymorphism 6.5 mmol /l region nature genet signi ficantly




2 Most Recent Publications

Heritabilities, apolipoprotein E, and effects of inbreeding on plasma lipids in a genetically isolated population: The Erasmus Rucphen family study (Article)
Isaacs, A. Sayed-Tabatabaei, F.A. Tikka-Kleemola, P. Aulchenko, Y.S. Zillikens, M.C. Sijbrands, E.J.G. Schut, A.F.C. Rutten, W.P.F. Pols, H.A.P. Witteman, J.C.M. Oostra, B.A.
2007-02-01
A mutation in SLC11A3 gene is associated with autosomal dominant hemochromatosis (Article)
Njajou, O.T. Vaessen, N. Dongen, J.W.F. van Heutink, P. Joosse, M. Berghuis, B. Breuning, M.H. Snijders, P.J.L.M. Rutten, W.P.F. Sandkuijl, L.A. Oostra, B.A. Duijn, C.M. van
2001-07-20